- Home
- LRMR vs SUJA Comparison
LRMR vs SUJA Comparison
Compare LRMR & SUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$3.92
N/A
Current Price
$8.85
Company Overview
Basic Information| Metric | LRMR | SUJA |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.8M | 426.8M |
| IPO Year | 2014 | 2026 |
Fundamental Metrics
Financial Performance| Metric | LRMR | SUJA |
|---|---|---|
| Price | $3.92 | $8.85 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.50 | N/A |
| AVG Volume (30 Days) | 857.9K | ★ 869.0K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,816.14 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.72 | $5.59 |
| 52 Week High | $6.42 | $11.93 |
Technical Indicators
Market Signals| Indicator | LRMR | SUJA |
|---|---|---|
| Relative Strength Index (RSI) | 44.77 | 51.02 |
| Support Level | $3.57 | $8.80 |
| Resistance Level | $4.21 | $10.94 |
| Average True Range (ATR) | 0.19 | 0.82 |
| MACD | -0.03 | 0.09 |
| Stochastic Oscillator | 20.39 | 54.65 |
Price Performance
Historical Comparison LRMR
SUJA
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.